Résumé
La prévalence des lésions liées à human papillomavirus (HPV) et la forte augmentation d’incidence du cancer anal chez les patients infectés par le VIH imposent un dépistage systématique dans cette population. Les facteurs de risque en dehors de l’homosexualité et de l’infection VIH sont: les partenaires multiples et des antécédents d’infection sexuellement transmissible (IST). Le dépistage à recommander, en 2008, est un examen proctologique complet avec anuscopie par un opérateur expérimenté. La fréquence des récidives impose un suivi régulier de ces patients.
Abstract
The prevalence of human papillomavirus (HPV) induced lesions and a significant increase in the incidence of anal cancer in patients infected by HIV mean that systematic screening is now necessary in this population. Risk factors, other than homosexuality and HIV infection, are: multiple partners and a history of sexually transmitted infections. In 2008 it is recommended that screening should involve a complete proctological examination with anoscopy, performed by an experienced operator. Frequency of recurrence means that such patients should be regularly monitored.
Références
Biggar RJ, Burnett W, Mikl J, Nasca P (1989) Cancer among New York men at risk of acquired immunodeficiency syndrome. Int J Cancer 43: 979–985
Daling JR, Weiss NS, Hislop TG, et al. (1987) Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 317: 973–977
Melbye M, Sprogel P (1991) Aetiological parallel between anal cancer and cervical cancer. Lancet 338: 657–659
Daling JR, Madeleine MM, Johnson LG, et al. (2004) Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 101: 270–280
Schiffman M, Castle PE, Jeronimo J, et al. (2007) Human papillomavirus and cervical cancer. Lancet 370: 890–907
Woodman CB, Collins S, Winter H, et al. (2001) Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357: 1831–1836
Ho GY, Bierman R, Beardsley L, et al. (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338: 423–428
Sobhani I, Walker F, Roudot-Thoraval F, et al. (2004) Anal carcinoma: incidence and effect of cumulative infections. AIDS 18: 1561–1569
Breese PL, Judson FN, Penley KA, et al. (1995) Anal human papillomavirus infection among homosexual and bisexual men: prevalence of type-specific infection and association with human immunodeficiency virus. Sex Transm Dis 22: 7–14
Weaver BA, Feng Q, Holmes KK, et al. (2004) Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis 189: 677–685
Palefsky JM, Holly EA, Ralston ML, et al. (1998) Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol 17: 320–326
Koutsky LA, Ault KA, Wheeler CM, et al. (2002) A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347: 1645–1651
Harper DM, Franco EL, Wheeler C, et al. (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364: 1757–1765
Palefsky JM, Berry JM, Jay N, et al. (2006) A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals. AIDS (London, England) 20: 1151–1155
Saliba G, Yeni P (2006) Recent and future therapeutic advances in the management of HIV infection. Pathol Biol 54: 545–550
Pineda CE, Berry JM, Jay N, et al. (2008) High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience. Dis Colon Rectum 51: 829–835
Abramowitz L, Benabderrahmane D, Ravaud P, et al. (2007) Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors. AIDS 21: 1457–1465
Edgren G, Sparen P (2007) Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study. Lancet Oncol 8: 311–316
Ogunbiyi OA, Scholefield JH, Raftery AT, et al. (1994) Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 81: 365–367
Chiao EY, Giordano TP, Palefsky JM, et al. (2006) Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis 43: 223–233
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Abramowitz, L., Aparicio, T. Surveillance des lésions anales précancéreuses et prévention. Colon Rectum 2, 138–144 (2008). https://doi.org/10.1007/s11725-008-0106-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11725-008-0106-8